Seres Therapeutics, Inc. (MCRB) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $0.64 | — |
| 2024 | $0.00 | +100.0% |
| 2023 | $-17.77 | -669.3% |
| 2022 | $-2.31 | -220.8% |
| 2021 | $-0.72 | +35.7% |
| 2020 | $-1.12 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $0.64 | — |
| 2024 | $0.00 | +100.0% |
| 2023 | $-17.77 | -669.3% |
| 2022 | $-2.31 | -220.8% |
| 2021 | $-0.72 | +35.7% |
| 2020 | $-1.12 | — |